Showing results (211-220 of 441) with videos related to
Sort By:
Pageof 45
Journal of Neuro-Oncology|April 29, 2020
Inhibition of protein phosphatase-2A with LB-100 enhances antitumor immunity against glioblastomaDominic Maggio, Winson S Ho, Rebecca Breese, et al.Journal of Neuro-Oncology|July 9, 2011
Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment deliveryMark R Gilbert, John Kuhn, Kathleen R Lamborn, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2018
MGMT Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical TrialsMonika E Hegi, Els Genbrugge, Thierry Gorlia, et al.The American Naturalist|July 29, 2008
The risk of flawed inference in evolutionary studies when detectability is less than oneOlivier Gimenez, Anne Viallefont, Anne Charmantier, et al.Neuro-Oncology|May 7, 2013
Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677Eva-Maria Ratai, Zheng Zhang, Bradley S Snyder, et al.Cancer Research|September 7, 2019
Mitochondrial NIX Promotes Tumor Survival in the Hypoxic Niche of GlioblastomaJinkyu Jung, Ying Zhang, Orieta Celiku, et al.Frontiers in Oncology|November 10, 2022
Metabolic biomarkers of radiotherapy response in plasma and tissue of an IDH1 mutant astrocytoma mouse modelVictor Ruiz-Rodado, Tyrone Dowdy, Adrian Lita, et al.NPJ Aging and Mechanisms of Disease|May 5, 2021
Impact of age on the circadian visual system and the sleep-wake cycle in mus musculusDorela D Shuboni-Mulligan, Demarrius L Young, Julianie De La Cruz Minyety, et al.International Journal of Radiation Oncology, Biology, Physics|April 20, 2010
Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous systemVictor A Levin, Luc Bidaut, Ping Hou, et al.Molecular Cancer Therapeutics|June 4, 2025
Beyond the Promoter: Total MGMT Gene Methylation Modulates Response to DNA Alkylating Agents in GliomaNicole J Briceno, Jinkyu Jung, Aiguo Li, et al.Pageof 45